DDInter948 DDInter341
Human interferon beta (165 residues), cysteine 17 is substituted with serine. Produced in E. coli, no carbohydrates, MW=18.5kD
On August 8, 2001 the U.S. Food and Drug Administration (FDA) announced that Bayer Pharmaceutical Division voluntarily withdrew Baycol from the U.S. market, due to reports of fatal rhabdomyolysis, a severe adverse reaction from this cholesterol-lowering (lipid-lowering) product. It has also been withdrawn from the Canadian market.[A669,L43942]
Cerivastatin {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Midostaurin
Cerivastatin {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Pegaspargase
Cerivastatin {u} may lead to a major life threatening interaction when taken with {v} Leflunomide
Cerivastatin {u} may lead to a major life threatening interaction when taken with {v} Fluconazole
Cerivastatin may cause a moderate interaction that could exacerbate diseases when taken with Midostaurin
Cerivastatin may cause a moderate interaction that could exacerbate diseases when taken with Pegaspargase
Cerivastatin may lead to a major life threatening interaction when taken with Leflunomide
Cerivastatin may lead to a major life threatening interaction when taken with Fluconazole